National Cancer Institute, Egypt   Report issue

Government Phase 2 Phase 3 Phase 4
Founded: Cairo Egypt (1969)

Organization Overview

First Clinical Trial
2014
NCT02180737
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ahmed Salah Ahmed Abd Elgalil | Assistant Professor of Anesthesia, intensive care and pain releif | National Cancer Institute, Egypt